Kane Waselenchuk is far and away the best racquetball player in the world, once winning a staggering 137 straight matches. He has won seven U.S. Open Racquetball Championships and is still at the peak of his game.
The drug industry is usually out front in assisting disaster relief, and many manufacturers have already come forth with major donations of money and supplies to Haiti in the aftermath of this week's earthquake.
In this digital era, we ask a lot more of you, our readers--to answer poll questions, provide feedback on articles, and most importantly to provide input for our surveys on key industry topics. Well, here we go again. There are two surveys that we'd love to get your input on:
In its neverending fight against both poor manufacturing practices and the manufacture and marketing of unapproved drugs, FDA has filed a Consent Decree and expects courts to prohibit Activis’ Totowa, New Jersey facility from further production.
At a meeting at DIA in Boston yesterday, Mike Svinte, President of Global Life Sciences at IBM provided a sneak peek and insights into a new report probing CEO challenges and concerns and their implications. The report, which is due to be released next month, will distill interviews with more...
On Tuesday afternoon, a panel discussed ways in which corporations might be able to stimulate the development of more therapies for serious diseases----the world’s top killers such as malaria. The topic is one that I’m very interested, but, unfortunately, I arrived late and missed much of the discussion.
Take two valium, get some anger-management counseling, and stop working for PhRMA.... I haven't been keeping up with the news too well lately. But I was surprised to learn from PharmaMarketing blog and PharmaGossip that T.V.
This comment was simply too good not to highlight. At its heart, the following irrefutable logic: "Capitalism drives the pharmaceutical industry, and it is foolish to think otherwise. Where idealism denies profit there will be no further drugs.
Oxfam just released a report on the development of drugs to treat the most prevalent diseases in developing nations. For a summary and to download the report, click here. It cites an unnamed consulting group that has put a price tag on the neglect.